The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors.

PubWeight™: 3.85‹?› | Rank: Top 1%

🔗 View Article (PMID 11385508)

Published in Nat Med on June 01, 2001

Authors

R Pola1, L E Ling, M Silver, M J Corbley, M Kearney, R Blake Pepinsky, R Shapiro, F R Taylor, D P Baker, T Asahara, J M Isner

Author Affiliations

1: Department of Medicine, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.

Articles citing this

(truncated to the top 100)

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science (2009) 18.40

Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. J Biol (2002) 3.85

Development, maintenance and disruption of the blood-brain barrier. Nat Med (2013) 2.62

Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell (2014) 2.62

Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development. Genes Dev (2006) 2.56

Targeting Hedgehog--a cancer stem cell pathway. Clin Cancer Res (2010) 2.50

Altered fracture repair in the absence of MMP9. Development (2003) 2.41

AngiomiRs--key regulators of angiogenesis. Curr Opin Genet Dev (2009) 2.40

Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol (2010) 2.05

A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci U S A (2008) 2.05

Three-dimensional analysis of vascular development in the mouse embryo. PLoS One (2008) 1.74

Temporal perturbations in sonic hedgehog signaling elicit the spectrum of holoprosencephaly phenotypes. J Clin Invest (2004) 1.74

IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev (2008) 1.73

Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ Res (2012) 1.70

FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network. Development (2007) 1.67

Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma. J Clin Invest (2012) 1.57

Overactivation of hedgehog signaling alters development of the ovarian vasculature in mice. Biol Reprod (2012) 1.52

Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med (2010) 1.41

The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development (2009) 1.41

Hedgehog signaling to distinct cell types differentially regulates coronary artery and vein development. Development (2008) 1.40

Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol (2012) 1.34

Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacol Rev (2010) 1.33

Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors. BMC Cancer (2004) 1.31

Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration. J Cell Mol Med (2008) 1.27

The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta (2012) 1.26

Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci U S A (2011) 1.23

The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron (2010) 1.21

Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells. PLoS One (2010) 1.21

Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature. Circ Res (2009) 1.20

Mechanisms regulating glioma invasion. Cancer Lett (2015) 1.19

The role of Hedgehog signaling in fibrogenic liver repair. Int J Biochem Cell Biol (2010) 1.18

Roles for Hedgehog signaling in adult organ homeostasis and repair. Development (2014) 1.17

Regulation of cavernous nerve injury-induced apoptosis by sonic hedgehog. Biol Reprod (2006) 1.17

Vascular development in the zebrafish. Cold Spring Harb Perspect Med (2012) 1.16

Differentiation of the brain vasculature: the answer came blowing by the Wnt. J Angiogenes Res (2010) 1.16

Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J Clin Invest (2003) 1.14

Noncanonical Hedgehog signaling. Vitam Horm (2012) 1.14

Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61. Oncogene (2011) 1.13

Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J Biol Chem (2011) 1.13

Multi-walled carbon nanotube-induced gene expression in the mouse lung: association with lung pathology. Toxicol Appl Pharmacol (2011) 1.13

Effects of aging on angiogenesis. Circ Res (2012) 1.10

Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation (2009) 1.10

Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation. Gut (2012) 1.08

Sonic Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-1/PKC pathway. PLoS One (2010) 1.08

Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells. J Mol Cell Cardiol (2010) 1.07

Hedgehog signaling induces arterial endothelial cell formation by repressing venous cell fate. Dev Biol (2010) 1.07

Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice. J Clin Invest (2010) 1.06

Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease. J Skin Cancer (2010) 1.06

Microparticles carrying Sonic hedgehog favor neovascularization through the activation of nitric oxide pathway in mice. PLoS One (2010) 1.04

Brothers and sisters: molecular insights into arterial-venous heterogeneity. Circ Res (2008) 1.03

Arterial versus venous endothelial cells. Cell Tissue Res (2008) 1.01

Tumor-stromal interactions in pancreatic cancer. Crit Rev Oncog (2013) 1.01

Genetic contributions to the development of retinopathy of prematurity. Pediatr Res (2009) 1.01

MicroRNAs in skin and wound healing. Physiol Genomics (2010) 1.00

Role of crosstalk between phosphatidylinositol 3-kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways in artery-vein specification. Circ Res (2008) 0.99

Sonic Hedgehog induces Notch target gene expression in vascular smooth muscle cells via VEGF-A. Arterioscler Thromb Vasc Biol (2009) 0.99

Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Rev Med Chem (2010) 0.99

Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair (2010) 0.99

Recombinant human sonic hedgehog protein regulates the expression of ZO-1 and occludin by activating angiopoietin-1 in stroke damage. PLoS One (2013) 0.98

Angiogenic factors stimulate growth of adult neural stem cells. PLoS One (2010) 0.98

Therapeutic angiogenesis: controlled delivery of angiogenic factors. Ther Deliv (2012) 0.97

Fishing for novel angiogenic therapies. Br J Pharmacol (2003) 0.97

Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor. Am J Pathol (2003) 0.96

Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells. Clin Cancer Res (2015) 0.96

Hedgehog signaling in prostate cancer and its therapeutic implication. Int J Mol Sci (2013) 0.96

Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis. Basic Res Cardiol (2009) 0.96

Normal and abnormal development of the aortic wall and valve: correlation with clinical entities. Neth Heart J (2014) 0.96

Extracellular vesicles as therapeutic tools in cardiovascular diseases. Front Immunol (2014) 0.95

An α-smooth muscle actin (acta2/αsma) zebrafish transgenic line marking vascular mural cells and visceral smooth muscle cells. PLoS One (2014) 0.95

Sonic hedgehog is required for vascular outgrowth in the hindbrain choroid plexus. Dev Biol (2010) 0.94

Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair. PLoS One (2013) 0.94

Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders. Neurochem Res (2011) 0.93

Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of Hedgehog pathway in a mouse model of colorectal cancer. Int J Mol Sci (2012) 0.93

Long-range enhancers modulate Foxf1 transcription in blood vessels of pulmonary vascular network. Histochem Cell Biol (2016) 0.93

Possible novel targets for therapeutic angiogenesis. Curr Opin Pharmacol (2008) 0.91

New molecular pathways in angiogenesis. Br J Cancer (2003) 0.91

The hedgehog pathway conditions the bone microenvironment for osteolytic metastasis of breast cancer. Int J Breast Cancer (2011) 0.91

Polymorphisms in the SUFU gene are associated with organ injury protection and sepsis severity in patients with Enterobacteriacea bacteremia. Infect Genet Evol (2013) 0.90

Converse conformational control of smoothened activity by structurally related small molecules. J Biol Chem (2009) 0.90

Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg (2013) 0.90

An anteroposterior wave of vascular inhibitor downregulation signals aortae fusion along the embryonic midline axis. Development (2010) 0.90

Pleiotropic beneficial effects of sonic hedgehog gene therapy in an experimental model of peripheral limb ischemia. Mol Ther (2011) 0.88

Sonic hedgehog promotes angiogenesis and osteogenesis in a coculture system consisting of primary osteoblasts and outgrowth endothelial cells. Tissue Eng Part A (2010) 0.88

Hedgehog signaling via a calcitonin receptor-like receptor can induce arterial differentiation independently of VEGF signaling in zebrafish. Blood (2012) 0.88

The Hedgehog transcription factor Gli3 modulates angiogenesis. Circ Res (2009) 0.87

Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization. Trends Cardiovasc Med (2007) 0.87

Inhibition of patched-1 prevents injury-induced neointimal hyperplasia. Arterioscler Thromb Vasc Biol (2013) 0.87

Sonic hedgehog is required for the assembly and remodeling of branchial arch blood vessels. Dev Dyn (2008) 0.87

Life is a pattern: vascular assembly within the embryo. Front Biosci (Elite Ed) (2012) 0.86

Control of blood vessel identity: from embryo to adult. Ann Vasc Dis (2008) 0.86

Sonic hedgehog: its expression in a healing cornea and its role in neovascularization. Mol Vis (2009) 0.86

Tissue plasminogen activator and plasminogen activator inhibitor 1 contribute to sonic hedgehog-induced in vitro cerebral angiogenesis. PLoS One (2012) 0.85

Endothelial primary cilia inhibit atherosclerosis. EMBO Rep (2016) 0.85

Estradiol triggers sonic-hedgehog-induced angiogenesis during peripheral nerve regeneration by downregulating hedgehog-interacting protein. Lab Invest (2012) 0.83

Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma. United European Gastroenterol J (2013) 0.83

Angiogenic therapy for cardiac repair based on protein delivery systems. Heart Fail Rev (2012) 0.83

Activation of Sonic hedgehog signaling in ventricular cardiomyocytes exerts cardioprotection against ischemia reperfusion injuries. Sci Rep (2015) 0.83

Stromal adipocyte enhancer-binding protein (AEBP1) promotes mammary epithelial cell hyperplasia via proinflammatory and hedgehog signaling. J Biol Chem (2012) 0.83

Hedgehog signaling in hematopoiesis. Crit Rev Eukaryot Gene Expr (2010) 0.83

Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench. Surgery (2012) 0.83

Articles by these authors

Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16

Kidney transplantation under FK 506. JAMA (1990) 7.45

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Nucleic acid reactivity and conformation. II. Reaction of cytosine and uracil with sodium bisulfite. J Biol Chem (1973) 4.44

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet (1996) 4.32

Mouse model of angiogenesis. Am J Pathol (1998) 4.28

Ore leaching by bacteria. Annu Rev Microbiol (1980) 4.28

Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation (2001) 4.17

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 4.10

Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol (2001) 3.97

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86

Mortality of sea lions along the central California coast linked to a toxic diatom bloom. Nature (2000) 3.82

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79

Age-dependent impairment of angiogenesis. Circulation (1999) 3.47

The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant (2011) 3.42

Apoptosis in human atherosclerosis and restenosis. Circulation (1995) 3.30

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11

Identification of a palmitic acid-modified form of human Sonic hedgehog. J Biol Chem (1998) 2.95

Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J Am Chem Soc (1974) 2.92

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation (1999) 2.92

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest (1999) 2.86

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol (1999) 2.83

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73

Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73

Medical education and health for all. Aust J Public Health (1995) 2.65

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol (2013) 2.51

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis (2010) 2.51

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48

Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol (1999) 2.48

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer (2009) 2.39

Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol (2001) 2.35

The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30

Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature (1967) 2.29

Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28

Thiobacillus acidophilus sp. nov.; isolation and some physiological characteristics. Can J Microbiol (1975) 2.28

On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. Biochemistry (1969) 2.25

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation (1998) 2.25

Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest (2001) 2.20

Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem (1995) 2.20

Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18

Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut (2007) 2.15

A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14

Congenital anomalies in American Indians of British Columbia. Genet Epidemiol (1986) 2.13

Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med (2000) 2.13

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation (2000) 2.12

Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem (1998) 2.12

Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation (1994) 2.08

Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation (1995) 2.07

Characteristic ribonucleolytic activity of human angiogenin. Biochemistry (1986) 2.06

Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation (2000) 2.05

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res (2000) 2.04

Our national obsession with potassium. Am J Med (1982) 2.02

A prospective study of preferred versus actual place of death among patients referred to a palliative care home-care service. Ir Med J (2002) 2.00